Digital Health News | pharmaphorum

News

Neuralink rival Precision raises $102m, and other financings

Neuralink rival Precision Neurosciences raises $102m for its brain-computer interface tech, plus financings for Redesign, DeepLife, TG0 and Tuva.

News

Study backs Closed Loop's drug+digital blood pressure plan

Closed Loop Medicine's smartphone app for blood pressure monitoring has shown proof-of-concept in the Cure-19 study.

News

Top podcaster spread health misinformation, claims BBC probe

Prominent podcaster Steven Bartlett has been accused of allowing health misinformation to be shared on his Diary of a CEO stream.

News

Ro co-founder and chief executive Zach Reitano

Lilly adds another sales channel for obesity drug Zepbound

Telehealth firm Ro will offer low-cost, single-dose vials of Lilly's obesity drug Zepbound, the first alternative to the new LillyDirect DTC channel.

News

Mulvany hits the reset button at BenevolentAI

The shape of BenevolentAI following the return of co-founder Ken Mulvany has started to crystallise and could see the company return to private hands.

News

Drug-digital dual therapy for depression starts phase 2

Gate Neurosciences' antidepressant apimostinel has started a proof-of-concept study to see if its efficacy can be boosted by a digital training tool.

Neuralink rival Precision raises $102m, and other financings

Study backs Closed Loop's drug+digital blood pressure plan

Top podcaster spread health misinformation, claims BBC probe

Lilly adds another sales channel for obesity drug Zepbound

Mulvany hits the reset button at BenevolentAI

Drug-digital dual therapy for depression starts phase 2

Spero snaps up Innovent immunology drug in strategic pivot

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks